Global Lice Treatment Market Set to Reach $1.5 Billion by 2030, Driven by Rising Prevalence of Infestations

News provided by

Oct 02, 2023, 10:30 ET

DUBLIN, Oct. 2, 2023 /PRNewswire/ -- The "Lice Treatment Market, By Product Type, By Distribution Channel, By Geography (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global lice treatment market is anticipated to witness substantial growth, with an expected value of $1.5 billion by 2030, up from $1 billion in 2023. This growth is projected at a Compound Annual Growth Rate (CAGR) of 6% during the forecast period.

Market Overview

Lice are parasitic insects that affect humans and are classified into three main types: body lice, head lice, and pubic lice. These tiny, wingless insects feed on human blood and are primarily transmitted through close contact and shared belongings. Effective treatment is essential to eliminate lice infestations. Lice treatment products are available both over-the-counter (OTC) and by prescription, helping to eradicate lice and manage the condition.

Key Drivers of Market Growth

The global lice treatment market is poised for growth due to several key factors. An increasing prevalence of lice infestations, the easy availability of lice treatment products, and heightened awareness among the population are expected to drive market expansion. Notably, the U.S. Food and Drug Administration (FDA) approved an over-the-counter (OTC) lotion for head lice treatment in October 2020. This Rx-to-OTC switch allowed nonprescription use of Sklice (ivermectin) lotion, 0.5%, for head lice treatment, further expanding access to treatment.

Market Segmentation

The global lice treatment market is segmented based on product type, distribution channel, and geography. Key segments include:

By Product Type:

OTC Medication
- Permethrin
- Pyrethrin
- Other Product Types
Prescription Medication
- Ivermectin
- Spinosad
- Malathion
- Other Prescription Medications

By Distribution Channel:

Hospitals and Clinics
Retail Pharmacies
Other Distribution Channels

By Geography:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

Key Players

Key companies in the global lice treatment market include Fleming Medical Ltd, ParaPRO, LLC, Prestige Consumer Healthcare Inc., Omega Pharma (A subsidiary of Perrigo Company plc), Alliance Pharma PLC, Oystershell, Johnson & Johnson Private Limited, GSK plc, and Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.).

Conclusion

The global lice treatment market is poised for substantial growth as the prevalence of lice infestations continues to rise, leading to increased demand for effective treatment solutions. The market's segmentation provides a comprehensive understanding of the factors contributing to this growth.

For more information about this report visit https://www.researchandmarkets.com/r/nl2p74

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets